Neomorph

San Diego, United States

Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.

Apr 2026

Series B

Top Investors

Longwood FundDeerfieldAlexandria Venture InvestmentsRegeneron VenturesBinney Street Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Neomorph's investors?

Neomorph's investors include Longwood Fund, Deerfield, Alexandria Venture Investments, Regeneron Ventures, Binney Street Capital.

Where is Neomorph headquartered?

Neomorph is headquartered in San Diego, United States.

What does Neomorph do?

Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.

What stage is Neomorph at?

Neomorph is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 13, 2026.

MLA

"Neomorph — Funding & Investors." VCBacked, April 13, 2026, https://www.vcbacked.co/company/neomorph. Accessed June 3, 2026.

APA

VCBacked. (2026). Neomorph — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/neomorph

Wikipedia (cite web)

{{cite web |title=Neomorph — Funding & Investors |url=https://www.vcbacked.co/company/neomorph |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 13, 2026.